Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07339800

Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value

Status
Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Invasive pulmonary fungal infections caused by Mucorales are rare but severe and rapidly progressive, affecting immunocompromised patients. The role of chest imaging in their diagnosis is well established in the 2020 EORTC/MSGERC criteria, and its use is almost systematic. However, the progression of lung parenchymal involvement and any potential prognostic radiological patterns in the follow-up of these infections are less well understood. This research aims to identify imaging characteristics predictive of favorable or unfavorable outcomes in infected patients, in order to better tailor follow-up and therapeutic options.

Conditions

Timeline

Start date
2025-09-18
Primary completion
2026-09-01
Completion
2026-09-19
First posted
2026-01-14
Last updated
2026-01-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07339800. Inclusion in this directory is not an endorsement.

Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value (NCT07339800) · Clinical Trials Directory